COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes
The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial des...
Gespeichert in:
| Veröffentlicht in: | World journal of gastroenterology : WJG 2023-02, Vol.29 (7), p.1123-1130 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1130 |
|---|---|
| container_issue | 7 |
| container_start_page | 1123 |
| container_title | World journal of gastroenterology : WJG |
| container_volume | 29 |
| creator | Said, Zeinab Nabil Ahmed El Habashy, Safinaz Adel Zaky, Samy |
| description | The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial describes liver involvement during COVID-19 infection in patients with or without preexisting liver injury, such as chronic liver disease, to elucidate COVID-19-induced liver function abnormalities and their severity, pathophysiology, clinical manifestations, and clinical and laboratory outcomes. We also discuss the effect of vaccination against COVID-19 to better understand host factors, such as age, gender, and race, on the incidence and severity of liver dysfunction at initial presentation and during the illness. Finally, we summarize the results of relevant meta-analyses published to date and highlight the importance of adequate liver function monitoring in the current climate of the overwhelming COVID-19 pandemic. |
| doi_str_mv | 10.3748/wjg.v29.i7.1123 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10011958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2788796110</sourcerecordid><originalsourceid>FETCH-LOGICAL-c394t-87fdac6791a0cb2988440d81adc87e6bea86b727e6271ed6775cca61f92990733</originalsourceid><addsrcrecordid>eNpVUU1PAjEUbIxGED17Mxy97NKPpR9ejMEvEhI4qNem2y1QstvFdhfDv7cIEj29l7yZeZMZAK4RTAnL-OBrtUg3WKSWpQhhcgK6GCORYJ7BU9BFELJEEMw64CKEFYSYkCE-Bx1CBaaUZl0wG00_xo9J5FhXtNoU_cYrF1RlnW1s6CtX9JfbtfG5La1vc-tMZdVdf-ZNMK5Rja3dD6huG11XJlyCs7kqg7k6zB54f356G70mk-nLePQwSTQRWZNwNi-UpkwgBXWOBedZBguOVKE5MzQ3itOc4bhihkxBGRtqrSiaCywEZIT0wP1ed93mlSl0NONVKdfeVspvZa2s_H9xdikX9UbGUBASQx4Vbg8Kvv5sTWhkZYM2ZamcqdsgMeOcCYoQjNDBHqp9HYI38-MfBOWuCBmLkLEIaZncFREZN3_tHfG_yZNvTP-GvA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2788796110</pqid></control><display><type>article</type><title>COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Said, Zeinab Nabil Ahmed ; El Habashy, Safinaz Adel ; Zaky, Samy</creator><creatorcontrib>Said, Zeinab Nabil Ahmed ; El Habashy, Safinaz Adel ; Zaky, Samy ; ESCMID Study Group for Viral Hepatitis ; ESCMID Study Group for Viral Hepatitis</creatorcontrib><description>The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial describes liver involvement during COVID-19 infection in patients with or without preexisting liver injury, such as chronic liver disease, to elucidate COVID-19-induced liver function abnormalities and their severity, pathophysiology, clinical manifestations, and clinical and laboratory outcomes. We also discuss the effect of vaccination against COVID-19 to better understand host factors, such as age, gender, and race, on the incidence and severity of liver dysfunction at initial presentation and during the illness. Finally, we summarize the results of relevant meta-analyses published to date and highlight the importance of adequate liver function monitoring in the current climate of the overwhelming COVID-19 pandemic.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v29.i7.1123</identifier><identifier>PMID: 36926664</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>COVID-19 - complications ; Humans ; Hyperbilirubinemia - etiology ; Liver Diseases - diagnosis ; Liver Diseases - epidemiology ; Liver Diseases - etiology ; Pandemics ; SARS-CoV-2</subject><ispartof>World journal of gastroenterology : WJG, 2023-02, Vol.29 (7), p.1123-1130</ispartof><rights>The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</rights><rights>The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c394t-87fdac6791a0cb2988440d81adc87e6bea86b727e6271ed6775cca61f92990733</citedby><cites>FETCH-LOGICAL-c394t-87fdac6791a0cb2988440d81adc87e6bea86b727e6271ed6775cca61f92990733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011958/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011958/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36926664$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Said, Zeinab Nabil Ahmed</creatorcontrib><creatorcontrib>El Habashy, Safinaz Adel</creatorcontrib><creatorcontrib>Zaky, Samy</creatorcontrib><creatorcontrib>ESCMID Study Group for Viral Hepatitis</creatorcontrib><creatorcontrib>ESCMID Study Group for Viral Hepatitis</creatorcontrib><title>COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes</title><title>World journal of gastroenterology : WJG</title><addtitle>World J Gastroenterol</addtitle><description>The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial describes liver involvement during COVID-19 infection in patients with or without preexisting liver injury, such as chronic liver disease, to elucidate COVID-19-induced liver function abnormalities and their severity, pathophysiology, clinical manifestations, and clinical and laboratory outcomes. We also discuss the effect of vaccination against COVID-19 to better understand host factors, such as age, gender, and race, on the incidence and severity of liver dysfunction at initial presentation and during the illness. Finally, we summarize the results of relevant meta-analyses published to date and highlight the importance of adequate liver function monitoring in the current climate of the overwhelming COVID-19 pandemic.</description><subject>COVID-19 - complications</subject><subject>Humans</subject><subject>Hyperbilirubinemia - etiology</subject><subject>Liver Diseases - diagnosis</subject><subject>Liver Diseases - epidemiology</subject><subject>Liver Diseases - etiology</subject><subject>Pandemics</subject><subject>SARS-CoV-2</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUU1PAjEUbIxGED17Mxy97NKPpR9ejMEvEhI4qNem2y1QstvFdhfDv7cIEj29l7yZeZMZAK4RTAnL-OBrtUg3WKSWpQhhcgK6GCORYJ7BU9BFELJEEMw64CKEFYSYkCE-Bx1CBaaUZl0wG00_xo9J5FhXtNoU_cYrF1RlnW1s6CtX9JfbtfG5La1vc-tMZdVdf-ZNMK5Rja3dD6huG11XJlyCs7kqg7k6zB54f356G70mk-nLePQwSTQRWZNwNi-UpkwgBXWOBedZBguOVKE5MzQ3itOc4bhihkxBGRtqrSiaCywEZIT0wP1ed93mlSl0NONVKdfeVspvZa2s_H9xdikX9UbGUBASQx4Vbg8Kvv5sTWhkZYM2ZamcqdsgMeOcCYoQjNDBHqp9HYI38-MfBOWuCBmLkLEIaZncFREZN3_tHfG_yZNvTP-GvA</recordid><startdate>20230221</startdate><enddate>20230221</enddate><creator>Said, Zeinab Nabil Ahmed</creator><creator>El Habashy, Safinaz Adel</creator><creator>Zaky, Samy</creator><general>Baishideng Publishing Group Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230221</creationdate><title>COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes</title><author>Said, Zeinab Nabil Ahmed ; El Habashy, Safinaz Adel ; Zaky, Samy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c394t-87fdac6791a0cb2988440d81adc87e6bea86b727e6271ed6775cca61f92990733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19 - complications</topic><topic>Humans</topic><topic>Hyperbilirubinemia - etiology</topic><topic>Liver Diseases - diagnosis</topic><topic>Liver Diseases - epidemiology</topic><topic>Liver Diseases - etiology</topic><topic>Pandemics</topic><topic>SARS-CoV-2</topic><toplevel>online_resources</toplevel><creatorcontrib>Said, Zeinab Nabil Ahmed</creatorcontrib><creatorcontrib>El Habashy, Safinaz Adel</creatorcontrib><creatorcontrib>Zaky, Samy</creatorcontrib><creatorcontrib>ESCMID Study Group for Viral Hepatitis</creatorcontrib><creatorcontrib>ESCMID Study Group for Viral Hepatitis</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Said, Zeinab Nabil Ahmed</au><au>El Habashy, Safinaz Adel</au><au>Zaky, Samy</au><aucorp>ESCMID Study Group for Viral Hepatitis</aucorp><aucorp>ESCMID Study Group for Viral Hepatitis</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World J Gastroenterol</addtitle><date>2023-02-21</date><risdate>2023</risdate><volume>29</volume><issue>7</issue><spage>1123</spage><epage>1130</epage><pages>1123-1130</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>The risk of liver injury in patients with coronavirus disease 2019 (COVID-19) infection is quite evident. Furthermore, liver function test abnormalities are still detected in COVID-19 patients despite the development of antivirals and the availability of several types of vaccines. This editorial describes liver involvement during COVID-19 infection in patients with or without preexisting liver injury, such as chronic liver disease, to elucidate COVID-19-induced liver function abnormalities and their severity, pathophysiology, clinical manifestations, and clinical and laboratory outcomes. We also discuss the effect of vaccination against COVID-19 to better understand host factors, such as age, gender, and race, on the incidence and severity of liver dysfunction at initial presentation and during the illness. Finally, we summarize the results of relevant meta-analyses published to date and highlight the importance of adequate liver function monitoring in the current climate of the overwhelming COVID-19 pandemic.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>36926664</pmid><doi>10.3748/wjg.v29.i7.1123</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1007-9327 |
| ispartof | World journal of gastroenterology : WJG, 2023-02, Vol.29 (7), p.1123-1130 |
| issn | 1007-9327 2219-2840 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10011958 |
| source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | COVID-19 - complications Humans Hyperbilirubinemia - etiology Liver Diseases - diagnosis Liver Diseases - epidemiology Liver Diseases - etiology Pandemics SARS-CoV-2 |
| title | COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T16%3A26%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19-induced%20transaminitis%20and%20hyperbilirubinemia:%20Presentation%20and%20outcomes&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Said,%20Zeinab%20Nabil%20Ahmed&rft.aucorp=ESCMID%20Study%20Group%20for%20Viral%20Hepatitis&rft.date=2023-02-21&rft.volume=29&rft.issue=7&rft.spage=1123&rft.epage=1130&rft.pages=1123-1130&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v29.i7.1123&rft_dat=%3Cproquest_pubme%3E2788796110%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2788796110&rft_id=info:pmid/36926664&rfr_iscdi=true |